The administration of pro re nata medications is the responsibility of the nurse. However, ethical uncertainties often happen due to the inability of incapacitated patients to collaborate with the nurse in the process of decision making for pro re nata medication administration. There is a lack of integrative knowledge and insufficient understanding regarding ethical considerations surrounding the administration of pro re nata medications to incapacitated patients. Therefore, they have been discussed in this paper and practical strategies to avoid unethical practices have been suggested. The complicated caring situation surrounding the administration of pro re nata medications is intertwined with ethical issues affecting the consideration of the patient's wishes and interventions that override them. The patient's right of autonomy and treatment refusal, surrogacy role, paternalism, and coercion are the main ethos of ethical pro re nata medication administration. Education and training can help nurses avoid legal and ethical issues in pro re nata medicines management and improve the quality and safety of healthcare. Empirical research is needed to improve our understanding of this phenomenon in the multidisciplinary environment of medicines management.
KeersRNHannMAlshehriGH, et al.Prevalence, nature and predictors of omitted medication doses in mental health hospitals: a multi-centre study. PLoS One2020; 15: e0228868.
3.
KeersRNWilliamsSDCookeJ, et al.Prevalence and nature of medication administration errors in health care settings: a systematic review of direct observational evidence. Ann Pharmacother2013; 47: 237–256.
4.
RostamiPHealCHarrisonA, et al.Prevalence, nature and risk factors for medication administration omissions in English NHS hospital inpatients: a retrospective multicentre study using medication safety thermometer data. BMJ Open2019; 9: e028170.
ManiasEKusljicSWuA. Interventions to reduce medication errors in adult medical and surgical settings: a systematic review. Ther Adv Drug Saf2020; 11: 2042098620968309.
8.
HayesCJacksonDDavidsonPM, et al.Medication errors in hospitals: a literature review of disruptions to nursing practice during medication administration. J Clin Nurs2015; 24: 3063–3076.
9.
MagalhãesAMMKrelingAChavesEHB, et al.Medication administration – nursing workload and patient safety in clinical wards. Rev Bras Enferm2019; 72: 183–189.
VaismoradiMAmaniyanSJordanS. Patient safety and pro re nata prescription and administration: a systematic review. Pharmacy (Basel)2018; 6: 95.
18.
HippKRepo-TiihonenEKuosmanenL, et al. Patient participation in pro re nata medication in forensic psychiatric care: a nursing document analysis. J Psychiatr Ment Health Nurs2021; 28:611–621.
19.
GordonDBDahlJPhillipsP, et al.The use of “as-needed” range orders for opioid analgesics in the management of acute pain: a consensus statement of the American Society for Pain Management Nursing and the American Pain Society. Pain Manag Nurs2004; 5: 53–58.
20.
GordonDBDahlJPhillipsP, et al.The use of ‘as-needed’ range orders for opioid analgesics in the management of acute pain: a consensus statement of the American Society for Pain Management Nursing and the American Pain Society. Home Healthc Nurse2005; 23: 388–396; quiz 397-388.
21.
MolloyLFieldJBeckettP, et al.PRN psychotropic medication and acute mental health nursing: reviewing the evidence. J Psychosoc Nurs Ment Health Serv2012; 50: 12–15.
22.
DörksMAllersKHoffmannF. Pro re nata drug use in nursing home residents: a systematic review. J Am Med Dir Assoc2019; 20: 287–293. e287.
23.
GriffithsAWSurrCAAlldredDP, et al.Pro re nata prescribing and administration for neuropsychiatric symptoms and pain in long-term care residents with dementia and memory problems: a cross-sectional study. Int J Clin Pharm2019; 41: 1314–1322.
24.
MartinKAroraVFischlerI, et al.Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital. Int J Ment Health Nurs2017; 26: 402–408.
25.
VaismoradiMVizcaya MorenoFSletvoldH, et al.PRN medicines management for psychotropic medicines in long-term care settings: a systematic review. Pharmacy (Basel, Switzerland)2019; 7: 157.
26.
WalshBDahlkeSO’RourkeH, et al.Nurses’ decision-making related to administering as needed psychotropic medication to persons with dementia: an empty systematic review. Int J Older People Nurs2021; 16: e12350.
27.
HippKKuosmanenLRepo-TiihonenE, et al.Patient participation in pro re nata medication in psychiatric inpatient settings: an integrative review. Int J Ment Health Nurs2018; 27: 536–554.
28.
UsherKHolmesCLindsayD, et al.PRN psychotropic medications: the need for nursing research. Contemp Nurse2003; 14: 248–257.
29.
DörksMSchmiemannGHoffmannF. Pro re nata (as needed) medication in nursing homes: the longer you stay, the more you get?Eur J Clin Pharmacol2016; 72: 995–1001.
SoltanianMMMolazemZMohammadiE,et al.Professional responsibility: an ethical concept extracted from practices of Iranian nurses during drug administration. Int J Pharm Res2018; 10: 346–353.
DodekPNorenaMAyasN, et al.Moral distress in intensive care unit personnel is not consistently associated with adverse medication events and other adverse events. J Crit Care2019; 53: 258–263.
36.
KarakachianAColbertA. Nurses’ moral distress, burnout, and intentions to leave: an integrative review. J Forensic Nurs2019; 15: 133–142.
Schröder-BäckPDuncanPSherlawW, et al.Teaching seven principles for public health ethics: towards a curriculum for a short course on ethics in public health programmes. BMC Med Ethics2014; 15: 73.
42.
CourtwrightARubinE. Who should decide for the unrepresented?Bioethics2016; 30: 173–180.
43.
PopeT. Unbefriended and unrepresented: better medical decision making for incapacitated patients without healthcare surrogates. Ga State Univ Law Rev2017; 33: 3.
KaplunovEHarveyN. The European proceedings of social & behavioural sciences EpSBS, volume XIX. In: CasatiFBaryshevaGAKriegerW (eds) Incapacitated patients’ wellbeing: surrogate decision making, 2017.
46.
MoyeJCatlinCKwakJ, et al.Ethical concerns and procedural pathways for patients who are incapacitated and alone: implications from a qualitative study for advancing ethical practice. HEC Forum2017; 29: 171–189.
47.
World Health Organization (WHO). A declaration on the promotion of patients’ rights in Europe. European consultation on the rights of patients Amsterdam 28–30 March 1994, https://www.who.int/genomics/public/eu_declaration1994.pdf (1994, accessed 11 March 2021).
48.
BarstowCShahanBRobertsM. Evaluating medical decision-making capacity in practice. Am Fam Physician2018; 98: 40–46.
49.
LeeGBWooHLeeSY, et al.The burden of care and the understanding of disease in Parkinson’s disease. PLoS One2019; 14: e0217581.
50.
RezaeiHNiksimaSHGhanei GheshlaghR. Burden of care in caregivers of Iranian patients with chronic disorders: a systematic review and meta-analysis. Health Qual Life Outcomes2020; 18: 261.
51.
KuljuKSuhonenRLeino-KilpiH. Ethical problems and moral sensitivity in physiotherapy: a descriptive study. Nurs Ethics2013; 20: 568–577.
52.
SequeiraAL-SLewisA. Ethical and legal considerations in the management of an unbefriended patient in a vegetative state. Neurocrit Care2017; 27: 173–179.
53.
DillesTVan RompaeyBVan BogaertP, et al.Resident and nurse reports of potential adverse drug reactions. Eur J Clin Pharmacol2015; 71: 741–749.
54.
MurrayL. The role of the registered nurse managing pro re nata (PRN) medicines in the care home (nursing): a case study of decision-making, medication management and resident involvement, http://hdl.handle.net/2299/17989; https://doi.org/10.18745/th.17989 (2017, accessed 11 March 2021).
55.
VirgolesiMPucciarelliGColantoniAM, et al.The effectiveness of a nursing discharge programme to improve medication adherence and patient satisfaction in the psychiatric intensive care unit. J Clin Nurs2017; 26: 4456–4466.
56.
BeauchampTChildressJ. Principles of Biomedical Ethics. 5th ed. New York: Oxford University Press, 2001.
57.
GillonR. Ethics needs principles—four can encompass the rest—and respect for autonomy should be “first among equals”. J Med Ethics2003; 29: 307–312.
58.
SjöstrandMHelgessonG. Coercive treatment and autonomy in psychiatry. Bioethics2008; 22: 113–120.
59.
RidAWesleyRPavlickM, et al.Patients’ priorities for treatment decision making during periods of incapacity: quantitative survey. Palliat Support Care2015; 13: 1165–1183.
60.
WendlerDWesleyBPavlickM, et al.A new method for making treatment decisions for incapacitated patients: what do patients think about the use of a patient preference predictor?J Med Ethics2016; 42: 235–241.
61.
KellyBRidAWendlerD. Systematic review: individuals’ goals for surrogate decision-making. J Am Geriatr Soc2012; 60: 884–895.
62.
RidAWendlerD. Can we improve treatment decision-making for incapacitated patients?Hastings Cent Rep2010; 40: 36–45.
63.
SussmanB. A narrative approach to the ethical dilemmas of surrogate decision making. Prog Palliat Care2015; 23: 137–141.
64.
SchweikartSJ. Who makes decisions for incapacitated patients who have no surrogate or advance directive?AMA J Ethics2019; 21: E587–E593.
Council of Europe. Convention for the protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. ETS No 164, https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/164 (1997, accessed 11 March 2021).
WhiteDBJonsenALoB. Ethical challenge: when clinicians act as surrogates for unrepresented patients. Am J Crit Care2012; 21: 202–207.
69.
Di GiulioPCrowR. Cognitive processes nurses and doctors use in the administration of PRN (at need) analgesic drugs. Scand J Caring Sci1997; 11: 12–19.
70.
Bygstad-LandroMGiskeT. Risking existence: the experience and handling of depression. J Clin Nurs2018; 27: e514–e522.
71.
HamersJPAbu-SaadHHvan den HoutMA, et al.Are children given insufficient pain-relieving medication postoperatively?J Adv Nurs1998; 27: 37–44.
72.
BrodtkorbKSkislandAVSlettebøÅ, et al.Ethical challenges in care for older patients who resist help. Nurs Ethics2015; 22: 631–641.
73.
MoermansVRABleijlevensMHCVerbeekH, et al.The use of involuntary treatment among older adults with cognitive impairment receiving nursing care at home: a cross-sectional study. Int J Nurs Stud2018; 88: 135–142.
74.
WheelerAJHuJProfittC, et al.Is higher psychotropic medication burden associated with involuntary treatment under the mental health act? A four-year Australian cohort study. BMC Psychiatry2020; 20: 294.
75.
MitchellV. Professional relationships. In: BarkerP (ed) Mental Health Ethics. New York: Routledge, 2011, pp. 149–159.
76.
SzmuklerGAppelbaumPS. Treatment pressures, leverage, coercion, and compulsion in mental health care. J Mental Health2008; 17: 233–244.
77.
DoubleD. The psychiatrist. In: BarkerP (ed) Mental Health Ethics: The Human Context. New York: Routledge, 2011, pp. 71–80.
78.
KashkaMSKeyserPK. Ethical issues in informed consent and ECT. Perspect Psychiatr Care1995; 31: 15–21; quiz 22-14.
79.
VenturaCAAAustinWCarraraBS, et al. Nursing care in mental health: human rights and ethical issues. Nurs Ethics2021; 28: 463–480.
80.
AnderssonUFathollahiJGustinLW. Nurses’ experiences of informal coercion on adult psychiatric wards. Nurs Ethics2020; 27: 741–753.
81.
LindMKaltiala-HeinoRSuominenT, et al.Nurses’ ethical perceptions about coercion. J Psychiatr Ment Health Nurs2004; 11: 379–385.
82.
Pelto-PiriVKjellinLHylénU, et al.Different forms of informal coercion in psychiatry: a qualitative study. BMC Res Notes2019; 12: 787.
83.
HotzyFJaegerM. Clinical relevance of informal coercion in psychiatric treatment-a systematic review. Front Psychiatry2016; 7: 197–197.
84.
ShalowitzDIGarrett-MayerEWendlerD. How should treatment decisions be made for incapacitated patients, and why?PLoS Med2007; 4: e35.
85.
KalaAK. Covert medication; the last option: a case for taking it out of the closet and using it selectively. Indian J Psychiatry2012; 54: 257–265.
86.
SheldonCT. Proof in the pudding: the value of a rights based approach to understanding the covert administration of psychotropic medication to adult inpatients determined to be decisionally incapable in Ontario’s psychiatric settings. J Law Med Ethics2017; 45: 170–181.
87.
ChiovittiRF. Theory of protective empowering for balancing patient safety and choices. Nurs Ethics2011; 18: 88–101.
88.
VaismoradiMJordanSLoganPA, et al.A systematic review of the legal considerations surrounding medicines management. Medicina (Kaunas)2021; 57: 65.
89.
RobertsM. Psychiatric ethics; a critical introduction for mental health nurses. J Psychiatr Ment Health Nurs2004; 11: 583–588.
90.
BalevreP. Is it legal to be crazy: an ethical dilemma. Arch Psychiatr Nurs2001; 15: 241–244.
91.
MyersS. Seclusion: a last resort measure. Perspect Psychiatr Care1990; 26: 24–28.
92.
LaurantMvan der BiezenMWijersN, et al.Nurses as substitutes for doctors in primary care. Cochrane Database Syst Rev2018; 7: Cd001271.
93.
MardaniAGriffithsPVaismoradiM. The role of the nurse in the management of medicines during transitional care: a systematic review. J Multidiscip Healthc2020; 13: 1347–1361.
94.
McDermott-LevyRLeffersJMayakaJ. Ethical principles and guidelines of global health nursing practice. Nurs Outlook2018; 66: 473–481.
